SEC Form 4 · accession 0001400482-16-000194
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD · M??????
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Takeuchi
Director
Period of report
Jul 12, 2016
Accepted (ET)
Jul 14, 2016 · 7:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001400482
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $15.41 | Jul 12, 2016 | A | 25,000 | A | — | Jul 12, 2026 | Common Stock | 25,000 | 55,000 | D |
Explanation of responses
- F1The options vest on a monthly pro rata basis over a four (4) year period that commenced on July 12, 2016 and will continue until July 12, 2020, at which time all of the options will be fully vested.
- F2The issuer's common stock trades on the Tokyo Stock Exchange under the symbol referenced in the issuer's registration statement on Form S-1 (File No. 333-192900).